Literature DB >> 12658081

Graft survival and glaucoma outcome after simultaneous penetrating keratoplasty and ahmed glaucoma valve implant.

Abdullah Al-Torbak1.   

Abstract

PURPOSE: To investigate the success of corneal graft and intraocular pressure (IOP) control after simultaneous penetrating keratoplasty (PKP) and Ahmed glaucoma valve implant in patients with coexisting corneal opacity and glaucoma.
METHODS: A retrospective review was undertaken of adult patients at King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, who underwent simultaneous PKP and Ahmed glaucoma valve implant between January 1994 and September 1999.
RESULTS: Twenty-five eyes of 25 patients were included in the study. Cumulative probabilities of success by Kaplan-Meier analysis showed 92% and 50% graft success and 92% and 86% IOP control at 1 and 3 years, respectively. The main postoperative complication was graft failure in 10 of 25 cases, and the majority of those failures resulted from immunologic graft rejection and tube endothelial touch.
CONCLUSION: Ahmed glaucoma valve implant is effective in controlling IOP in a majority of eyes during a 3-year time span. However, corneal graft success continues to pose challenges.

Entities:  

Mesh:

Year:  2003        PMID: 12658081     DOI: 10.1097/00003226-200304000-00002

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  20 in total

1.  Intraocular pressure control with Ahmed glaucoma drainage device in patients with cicatricial ocular surface disease-associated or aniridia-related glaucoma.

Authors:  Radwan Almousa; Damian B Lake
Journal:  Int Ophthalmol       Date:  2013-10-18       Impact factor: 2.031

2.  Outcome of Descemet stripping automated endothelial keratoplasty in eyes with an Ahmed glaucoma valve.

Authors:  Patrick J Chiam; Robert Cheeseman; Vivian W Ho; Vito Romano; Anshoo Choudhary; Mark Batterbury; Stephen B Kaye; Colin E Willoughby
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-03-17       Impact factor: 3.117

3.  Five-year outcomes of eyes with glaucoma drainage device and penetrating keratoplasty.

Authors:  Robert M Knape; Tiffany N Szymarek; Sonal S Tuli; William T Driebe; Mark B Sherwood; Mary Fran Smith
Journal:  J Glaucoma       Date:  2012-12       Impact factor: 2.503

4.  Effect of shunt type on rates of tube-cornea touch and corneal decompensation after tube shunt surgery in uveitic glaucoma.

Authors:  Sapna Sinha; Allen Y Ganjei; Melih Ustaoglu; Zeba A Syed; Daniel Lee; Jonathan S Myers; Scott J Fudemberg; Reza Razeghinejad
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-30       Impact factor: 3.117

Review 5.  The challenging management of pediatric corneal transplantation: an overview of surgical and clinical experiences.

Authors:  Antonio Di Zazzo; Stefano Bonini; Salvatore Crugliano; Michele Fortunato
Journal:  Jpn J Ophthalmol       Date:  2017-04-03       Impact factor: 2.447

6.  Intravitreal injection of tissue plasminogen activator as treatment for an occluded pars plana glaucoma tube.

Authors:  Irena Tsui; Suzanna Airiani; Angie Wen; Tarek El-Sawy; Howard F Fine; Peter J G Maris
Journal:  Clin Ophthalmol       Date:  2009-06-02

Review 7.  Glaucoma management after corneal transplantation surgeries.

Authors:  Helen L Kornmann; Steven J Gedde
Journal:  Curr Opin Ophthalmol       Date:  2016-03       Impact factor: 3.761

Review 8.  Graft failure: III. Glaucoma escalation after penetrating keratoplasty.

Authors:  Emily C Greenlee; Young H Kwon
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

Review 9.  Post-penetrating keratoplasty glaucoma.

Authors:  Tanuj Dada; Anand Aggarwal; K B Minudath; M Vanathi; Sunil Choudhary; Viney Gupta; Ramanjit Sihota; Anita Panda
Journal:  Indian J Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 1.848

10.  The efficacy of Ahmed glaucoma valve drainage devices in cases of adult refractory glaucoma in Indian eyes.

Authors:  Jitendra K S Parihar; Devendra P Vats; Rakesh Maggon; Vijay Mathur; Anirudh Singh; Sanjay K Mishra
Journal:  Indian J Ophthalmol       Date:  2009 Sep-Oct       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.